ClearanceBrief
Recall Z-0845-05 ยท FPA Set, Administration, Intravascular

Baxter Healthcare Corp.

Baxter ClearLink Intravenous (IV) Solution Sets and Extension Sets that have a ClearLink luer activated valve for IV access, which allows the administration of medications/solutions with a needleless luer syringe; Baxter Healthcare Corporation, Deerfield, IL 60015 USA

DateMay 17, 2005 (initiated Feb 28, 2005)
StatusTerminated
ReasonPossible occlusion of the Clearlink injection site valve due to inadequate silicone lubrication of the slit in the upper seal of the valve.
Root causeOther
ActionRecall letters dated 2/28/05 were sent to the direct accounts via first class mail on the same date to the attention of the Director of Nursing. The accounts were informed of the increase in reports of ClearLink valve occlusion, requested to examine their inventory for the affected lots of product, and call Baxter Healthcare Center for Service at 1-888-229-001 to return the affected product for credit. The letters included a copy of the Technical Letter revised 5/4/04, outlining the correct preparation and use ClearLink valve product, including detecting valve re-knits.
Quantity1,171,116 sets
DistributionNationwide, including Puerto Rico and American Samoa, and internationally to Canada, Panama, Australia, New Zealand and Venezuela.
FDA recordOpen on fda.gov

510(k) clearances named in this recall

K003225SOLUTION ADMINISTRATION SETS WITH CAPLESS LUER ACTIVATED VALVE
Baxter Healthcare Corp, Oct 19, 2000
K791496LOW PLASTICIZER ADMINISTRATION SETS
Travenol Laboratories, S.A., Apr 8, 1980
K961225CONTINUFLO SOLUTION SET/SECONDARY MEDICATION SET
Baxter Healthcare Corp, Jun 21, 1996
K962581STOPCOCK MANIFOLD GANGS
Baxter Healthcare Corp, Aug 28, 1996
K984381BURETROL SOLUTION SETS
Baxter Healthcare Corp, Feb 19, 1999